About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
2022
2021
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies
By
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
FEATURING
Erin Roesch
By
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
FEATURING
Erin Roesch
193 views
March 8, 2021
0 Comments
Login to view comments.
Click here to Login
2021
13:53
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic Expert BC Discussion: Commercial CTC Assays, ILD, R…
Feat.
M. Miller,
E. Roesch,
J. Abraham
12:48
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Prognostic Models & Biomarker Evaluation in mBC: Does Sacituzuma…
Feat.
E. Roesch
15:48
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Ac…
Feat.
E. Roesch
28:52
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic Updates on BC Surgery: How to Refine Axilla Managem…
Feat.
M. Miller
09:00
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…
Feat.
J. Abraham
14:19
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
2021 Update on HER2+ MBC: Neratinib/Cape vs. Lapatinib/Cape in MBC, …
Feat.
J. Abraham
17:28
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic Expert Discussion on BC: Chemo Benefit With Ovarian…
Feat.
J. Martin,
H. Moore,
E. Harris,
M. Kruse
24:29
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic Updates on IO in mTNBC: Should We Use Atezo With Pa…
Feat.
M. Kruse
08:07
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic Updates on IO in Early Stage TNBC: Will pCR Increas…
Feat.
M. Kruse
21:39
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Cleveland Clinic 2021 BC RT Updates: WBRT vs. APBI, 1-Week vs. 3-Wee…
Feat.
E. Harris
12:24
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Breast Cancer Screening and Prevention: Anastrozole vs. Tamoxifen fo…
Feat.
H. Moore
10:34
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
BC Survivorship Updates: Diabetes Risk Reduction Diet & Survival…
Feat.
H. Moore
08:36
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
2021 RxPONDER Study Update on Early HR+/N+ BC: How Does Chemo Affect…
Feat.
J. Martin
06:12
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC…
Feat.
J. Martin
09:22
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
2021 Update on ET in BC: Palbociclib+ET in HR+/HER2- Normal Disease …
Feat.
J. Martin
